PFE — Pfizer Cashflow Statement
0.000.00%
Last trade - 00:00- $129.99bn
- $174.16bn
- $63.63bn
- 99
- 80
- 73
- 97
Annual cashflow statement for Pfizer, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9,652 | 22,025 | 31,407 | 2,158 | 8,062 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1,717 | -3,147 | 1,016 | 5,868 | 2,836 |
| Discontinued Operations | |||||
| Extraordinary Items | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -275 | 12,804 | -4,456 | -2,174 | -3,065 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 14,403 | 32,580 | 29,267 | 8,700 | 12,744 |
| Capital Expenditures | -2,791 | -2,711 | -3,236 | -3,907 | -2,909 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1,480 | -19,835 | -12,547 | -28,371 | 5,561 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4,271 | -22,546 | -15,783 | -32,278 | 2,652 |
| Financing Cash Flow Items | 11,121 | 16 | -335 | -632 | -469 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -9,649 | -9,816 | -14,834 | 26,066 | -17,140 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 475 | 159 | -1,515 | 2,448 | -1,810 |